Electromyography for Diaphragm Effort (Edi2Pdi)

May 19, 2020 updated by: Prof.dr. L.M.A. Heunks, Amsterdam UMC, location VUmc

Diaphragm Electromyography to Estimate Breathing Effort: a Physiological Study

Mechanical ventilation may be necessary to save the life of a patient due to an accident, pneumonia or surgery. The ventilator then temporarily takes over the function of the respiratory muscles. During treatment in the Intensive Care, the amount of support provided by the ventilator is usually lowered gradually, until the point that the patient can breathe unassisted once again. However, in a large fraction of patients (up to 40%) it takes days to weeks before the patient is able to breathe unassisted, even after the initial disease has been treated. This is called prolonged weaning.

A possible cause of prolonged weaning is weakness of the respiratory muscles. The diaphragm, the largest respiratory muscle, can become weakened if it is used too little, much like all other muscles in the body. Additionally, damage and weakness of the diaphragm can occur when the diaphragm has to work excessively. Therefore, it is important that the diaphragm works enough; not so little that it becomes weakened, but not too much either.

Measurements of pressure generated by the diaphragm are needed to determine the current level of diaphragm activity in a patient on mechanical ventilation. However, these measurements are rarely performed, because they are time-consuming and require placement of two additional nasogastric catheters. This is a shame, as adequate loading of the diaphragm might prevent development of weakness, leading to shorter duration of mechanical ventilation. Finding alternative measurements of diaphragm effort might be a solution to this problem.

It has been hypothesized that the electrical activity of the diaphragm provides a reliable indication of diaphragm effort. This study aims to determine whether there is a correlation between pressure generation by the diaphragm and electrical activity of the diaphragm over a wide range of respiratory activity, from low effort to extreme effort, in healthy volunteers.

Study Overview

Study Type

Interventional

Enrollment (Actual)

17

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Noord-Holland
      • Amsterdam, Noord-Holland, Netherlands, 1081HV
        • Amsterdam UMC, location VUmc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Informed Consent
  • Age >18 years

Exclusion Criteria:

  • History of cardiac and/or pulmonary disease or current medication use
  • History of pneumothorax
  • Contra-indications for nasogastric tube placement (recent epistaxis, severe coagulopathy, current upper airway pathology)
  • Contra-indication for magnetic stimulation (cardiac pacemakers or metal in cervical area)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Intervention group, receiving Inspiratory threshold loading protocol.
Subjects will be instrumented with catheters that measure electrical activity of the diaphragm and transdiaphragmatic pressure. Subjects will perform a stepwise inspiratory threshold loading protocol to induce a wide range of diaphragm activity.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electrical activity of the diaphragm
Time Frame: Electrical activity of the diaphragm will be assessed at multiple levels of breathing effort in each subject for two hours.
Diaphragm electromyography will be obtained with multiple electrode pairs situated on specialized esophageal catheters. The raw diaphragm electromyography will be filtered and integrated to obtain the compound mean action potential reported in microvolts (μV) as described in ref 1 (Sinderby et al.).
Electrical activity of the diaphragm will be assessed at multiple levels of breathing effort in each subject for two hours.
Transdiaphragmatic pressure
Time Frame: Transdiaphragmatic pressure will be assessed at multiple levels of breathing effort in each subject for two hours.
The pressure gradient over the diaphragm will be obtained by subtracting the esophageal pressure from the pressure in the stomach, measured with specialized catheters, and will be reported in centimeters of water (cmH2O) as described in ref 3, American Thoracic Society (ATS) statement on respiratory muscle testing.
Transdiaphragmatic pressure will be assessed at multiple levels of breathing effort in each subject for two hours.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Work of breathing
Time Frame: Work of breathing will be assessed at multiple levels of breathing effort in each subject for two hours.
Work of breathing will be obtained by integrating the pressure-volume loops of esophageal pressure and tidal volume, and will be reported in Joule per minute as described in ref 3, ATS statement on respiratory muscle testing..
Work of breathing will be assessed at multiple levels of breathing effort in each subject for two hours.
Pressure-time product of the diaphragm
Time Frame: Pressure-time product of the diaphragm will be assessed at multiple levels of breathing effort in each subject for two hours.
Pressure-time product of the diaphragm will be obtained by dividing the time-integral of transdiaphragmatic pressure (described above) over time, and will be reported as cmH20*s per minute as described in ref 3, ATS statement on respiratory muscle testing..
Pressure-time product of the diaphragm will be assessed at multiple levels of breathing effort in each subject for two hours.
Pressure-time product of the respiratory muscles
Time Frame: Pressure-time product of the respiratory muscles will be assessed at multiple levels of breathing effort in each subject for two hours.
Pressure-time product of the respiratory muscles will be obtained by dividing the time-integral of esophageal pressure over time, and will be reported as cmH20*s per minute as described in ref 3, ATS statement on respiratory muscle testing..
Pressure-time product of the respiratory muscles will be assessed at multiple levels of breathing effort in each subject for two hours.
Mechanical power
Time Frame: Mechanical power will be assessed at multiple levels of breathing effort in each subject for two hours.
Mechanical power will be obtained by multiplying the work of breathing (described above) by the number of breaths per minute, and will be reported in Watt (joule/minute) as described in ref 3, ATS statement on respiratory muscle testing..
Mechanical power will be assessed at multiple levels of breathing effort in each subject for two hours.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accessory muscle recruitment
Time Frame: Two hours.
As an explorative end-point, the timepoint at which several accessory inspiratory muscles are recruited during incremental respiratory loading will be studied and reported (if technically possible)
Two hours.
Diaphragm thickening fraction.
Time Frame: Thickening fractions will be obtained at multiple levels of breathing effort in each subject for up to two hours
Using a linear probe positioned in the mid-axillary line the diaphragm will be visualized as per clinical protocol. Diaphragm thickness will be measured during inspiration and expiration and will be reported in mm. Thickening fraction will be obtained with the following formula: (Thickness during inspiration - thickness during expiration) / thickness during expiration * 100% as described in ref 2 (Vivier et al.).
Thickening fractions will be obtained at multiple levels of breathing effort in each subject for up to two hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Angelique Spoelstra - de Man, MD, PhD, Amsterdam UMC, location VUmc
  • Principal Investigator: Leo Heunks, MD, PhD, Amsterdam UMC, location VUmc

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 16, 2018

Primary Completion (Actual)

April 15, 2019

Study Completion (Actual)

April 30, 2019

Study Registration Dates

First Submitted

June 8, 2018

First Submitted That Met QC Criteria

June 25, 2018

First Posted (Actual)

July 9, 2018

Study Record Updates

Last Update Posted (Actual)

May 20, 2020

Last Update Submitted That Met QC Criteria

May 19, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Weakness

Clinical Trials on Inspiratory threshold loading protocol

3
Subscribe